To prove this point, he and Saito applied their miRNA switches to the purification of hepatocytes and pancreatic cells, neither of which has
unique cell surface markers, finding miRNA switches effective there too.
The cancer
cell marker that Johnson and her team identified was a specific change in protein glycosylation, that is, a
unique pattern of sugars decorating a protein found on the
cell surface.